Predicting liver-related events in NAFLD: A predictive model

Area of Science:

• Hepatology
• Medical Informatics
• Predictive Modeling

Background:

• Non-alcoholic fatty liver disease (NAFLD) management requires accurate prediction of patient outcomes.
• Fibrosis staging is a common surrogate for predicting outcomes in NAFLD.
• There is a need for models that directly predict liver-related events (LREs).

Purpose of the Study:

• To develop and validate a predictive model for liver-related events (LREs) in NAFLD patients.
• To compare the accuracy of the new model against established fibrosis prediction models.
• To identify key clinical predictors of LREs in NAFLD.

Main Methods:

• Development and validation of a predictive model using competing risk regression on derivation and validation cohorts (n=584, n=477).
• Inclusion of clinical variables such as age, type 2 diabetes, albumin, bilirubin, platelet count, and international normalized ratio.
• Accuracy assessment using time-dependent Area Under the Curve (AUC) analysis and calibration metrics.

Main Results:

• The NAFLD Outcomes Score (NOS) was developed, incorporating readily available clinical measures.
• The NOS demonstrated excellent calibration and performance in both derivation and validation cohorts.
• NOS showed superior accuracy (time-dependent AUC) compared to FIB-4 and NAFLD Fibrosis Score for predicting LREs at 5 and 10 years.

Conclusions:

• The NAFLD Outcomes Score (NOS) is a validated tool for predicting liver-related events in NAFLD.
• NOS offers greater predictive accuracy for patient outcomes than current fibrosis staging models.
• The model utilizes easily accessible clinical data, facilitating clinical application.